Literature DB >> 24486181

UHRF1 overexpression drives DNA hypomethylation and hepatocellular carcinoma.

Raksha Mudbhary1, Yujin Hoshida2, Yelena Chernyavskaya3, Vinitha Jacob1, Augusto Villanueva4, M Isabel Fiel5, Xintong Chen2, Kensuke Kojima2, Swan Thung5, Roderick T Bronson6, Anja Lachenmayer7, Kate Revill8, Clara Alsinet9, Ravi Sachidanandam10, Anal Desai11, Sucharita SenBanerjee11, Chinweike Ukomadu11, Josep M Llovet12, Kirsten C Sadler13.   

Abstract

Ubiquitin-like with PHD and RING finger domains 1 (UHRF1) is an essential regulator of DNA methylation that is highly expressed in many cancers. Here, we use transgenic zebrafish, cultured cells, and human tumors to demonstrate that UHRF1 is an oncogene. UHRF1 overexpression in zebrafish hepatocytes destabilizes and delocalizes Dnmt1 and causes DNA hypomethylation and Tp53-mediated senescence. Hepatocellular carcinoma (HCC) emerges when senescence is bypassed. tp53 mutation both alleviates senescence and accelerates tumor onset. Human HCCs recapitulate this paradigm, as UHRF1 overexpression defines a subclass of aggressive HCCs characterized by genomic instability, TP53 mutation, and abrogation of the TP53-mediated senescence program. We propose that UHRF1 overexpression is a mechanism underlying DNA hypomethylation in cancer cells and that senescence is a primary means of restricting tumorigenesis due to epigenetic disruption.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24486181      PMCID: PMC3951208          DOI: 10.1016/j.ccr.2014.01.003

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  63 in total

1.  Conservation and divergence of methylation patterning in plants and animals.

Authors:  Suhua Feng; Shawn J Cokus; Xiaoyu Zhang; Pao-Yang Chen; Magnolia Bostick; Mary G Goll; Jonathan Hetzel; Jayati Jain; Steven H Strauss; Marnie E Halpern; Chinweike Ukomadu; Kirsten C Sadler; Sriharsa Pradhan; Matteo Pellegrini; Steven E Jacobsen
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-15       Impact factor: 11.205

2.  Focal gains of VEGFA and molecular classification of hepatocellular carcinoma.

Authors:  Derek Y Chiang; Augusto Villanueva; Yujin Hoshida; Judit Peix; Philippa Newell; Beatriz Minguez; Amanda C LeBlanc; Diana J Donovan; Swan N Thung; Manel Solé; Victoria Tovar; Clara Alsinet; Alex H Ramos; Jordi Barretina; Sasan Roayaie; Myron Schwartz; Samuel Waxman; Jordi Bruix; Vincenzo Mazzaferro; Azra H Ligon; Vesna Najfeld; Scott L Friedman; William R Sellers; Matthew Meyerson; Josep M Llovet
Journal:  Cancer Res       Date:  2008-08-15       Impact factor: 12.701

3.  DNA demethylase activity maintains intestinal cells in an undifferentiated state following loss of APC.

Authors:  Kunal Rai; Sharmistha Sarkar; Talmage J Broadbent; Matthew Voas; Kenneth F Grossmann; Lincoln D Nadauld; Somaye Dehghanizadeh; Fanuel T Hagos; Yumei Li; Rachel K Toth; Stephanie Chidester; Timothy M Bahr; W Evan Johnson; Brad Sklow; Randall Burt; Bradley R Cairns; David A Jones
Journal:  Cell       Date:  2010-09-17       Impact factor: 41.582

4.  UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer.

Authors:  Wei Jin; Li Chen; Ying Chen; Si-Guang Xu; Gen-Hong Di; Wen-Jin Yin; Jiong Wu; Zhi-Ming Shao
Journal:  Breast Cancer Res Treat       Date:  2009-11-27       Impact factor: 4.872

5.  Loss of Dnmt1 catalytic activity reveals multiple roles for DNA methylation during pancreas development and regeneration.

Authors:  Ryan M Anderson; Justin A Bosch; Mary G Goll; Daniel Hesselson; P Duc Si Dong; Donghun Shin; Neil C Chi; Chong Hyun Shin; Amnon Schlegel; Marnie Halpern; Didier Y R Stainier
Journal:  Dev Biol       Date:  2009-07-22       Impact factor: 3.582

6.  Pivotal role of mTOR signaling in hepatocellular carcinoma.

Authors:  Augusto Villanueva; Derek Y Chiang; Pippa Newell; Judit Peix; Swan Thung; Clara Alsinet; Victoria Tovar; Sasan Roayaie; Beatriz Minguez; Manel Sole; Carlo Battiston; Stijn Van Laarhoven; Maria I Fiel; Analisa Di Feo; Yujin Hoshida; Steven Yea; Sara Toffanin; Alex Ramos; John A Martignetti; Vincenzo Mazzaferro; Jordi Bruix; Samuel Waxman; Myron Schwartz; Matthew Meyerson; Scott L Friedman; Josep M Llovet
Journal:  Gastroenterology       Date:  2008-08-20       Impact factor: 22.682

7.  Sorafenib in advanced hepatocellular carcinoma.

Authors:  Josep M Llovet; Sergio Ricci; Vincenzo Mazzaferro; Philip Hilgard; Edward Gane; Jean-Frédéric Blanc; Andre Cosme de Oliveira; Armando Santoro; Jean-Luc Raoul; Alejandro Forner; Myron Schwartz; Camillo Porta; Stefan Zeuzem; Luigi Bolondi; Tim F Greten; Peter R Galle; Jean-François Seitz; Ivan Borbath; Dieter Häussinger; Tom Giannaris; Minghua Shan; Marius Moscovici; Dimitris Voliotis; Jordi Bruix
Journal:  N Engl J Med       Date:  2008-07-24       Impact factor: 91.245

8.  Recognition of hemi-methylated DNA by the SRA protein UHRF1 by a base-flipping mechanism.

Authors:  Kyohei Arita; Mariko Ariyoshi; Hidehito Tochio; Yusuke Nakamura; Masahiro Shirakawa
Journal:  Nature       Date:  2008-09-03       Impact factor: 49.962

9.  Structural basis for recognition of hemi-methylated DNA by the SRA domain of human UHRF1.

Authors:  George V Avvakumov; John R Walker; Sheng Xue; Yanjun Li; Shili Duan; Christian Bronner; Cheryl H Arrowsmith; Sirano Dhe-Paganon
Journal:  Nature       Date:  2008-09-03       Impact factor: 49.962

10.  UHRF1 is a novel diagnostic marker of lung cancer.

Authors:  M Unoki; Y Daigo; J Koinuma; E Tsuchiya; R Hamamoto; Y Nakamura
Journal:  Br J Cancer       Date:  2010-06-01       Impact factor: 7.640

View more
  133 in total

Review 1.  Zebrafish: an important tool for liver disease research.

Authors:  Wolfram Goessling; Kirsten C Sadler
Journal:  Gastroenterology       Date:  2015-08-28       Impact factor: 22.682

2.  Epigenetic Compensation Promotes Liver Regeneration.

Authors:  Shuang Wang; Chi Zhang; Dan Hasson; Anal Desai; Sucharita SenBanerjee; Elena Magnani; Chinweike Ukomadu; Amaia Lujambio; Emily Bernstein; Kirsten C Sadler
Journal:  Dev Cell       Date:  2019-06-20       Impact factor: 12.270

3.  An Atypical Oncogene Within the Atypical E2Fs.

Authors:  Mónica Álvarez-Fernández; Marcos Malumbres
Journal:  J Natl Cancer Inst       Date:  2015-06-18       Impact factor: 13.506

4.  IBD. Fishing for missing heritability in IBD.

Authors:  Michael Pack
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-05-05       Impact factor: 46.802

Review 5.  Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.

Authors:  Yuan Cheng; Cai He; Manni Wang; Xuelei Ma; Fei Mo; Shengyong Yang; Junhong Han; Xiawei Wei
Journal:  Signal Transduct Target Ther       Date:  2019-12-17

6.  PIM1 induces cellular senescence through phosphorylation of UHRF1 at Ser311.

Authors:  J Yang; K Liu; J Yang; B Jin; H Chen; X Zhan; Z Li; L Wang; X Shen; M Li; W Yu; Z Mao
Journal:  Oncogene       Date:  2017-04-10       Impact factor: 9.867

7.  DNA hypomethylation induces a DNA replication-associated cell cycle arrest to block hepatic outgrowth in uhrf1 mutant zebrafish embryos.

Authors:  Vinitha Jacob; Yelena Chernyavskaya; Xintong Chen; Poh Seng Tan; Brandon Kent; Yujin Hoshida; Kirsten C Sadler
Journal:  Development       Date:  2015-01-06       Impact factor: 6.868

8.  [Expression of Wnt5b in patients with HBV-related hepatocellular carcinoma and its clinical significance].

Authors:  Le-Yang Xiang; Huo-Hui Ou; Zhan-Jun Chen; Ying-Hao Fang; Yu Huang; Xiang-Hong Li; Ding-Hua Yang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-08-20

Review 9.  Zebrafish as a disease model for studying human hepatocellular carcinoma.

Authors:  Jeng-Wei Lu; Yi-Jung Ho; Yi-Ju Yang; Heng-An Liao; Shih-Ci Ciou; Liang-In Lin; Da-Liang Ou
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

10.  Clinicopathological analysis of UHRF1 expression in medulloblastoma tissues and its regulation on tumor cell proliferation.

Authors:  Zhen-Yu Zhang; Jia-Jun Cai; Jin Hong; Kay Ka-Wai Li; Zhou Ping; Yin Wang; Ho-Keung Ng; Yu Yao; Ying Mao
Journal:  Med Oncol       Date:  2016-07-23       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.